P012?Efficacy of Exclusive Enteral Nutrition and Weekly Adalimumab Combination in Crohn's Patients With Fibroinflammatory Stenosis

dc.authorscopusid57403396800
dc.contributor.authorTokmak, Salih
dc.date.accessioned2023-07-26T11:50:17Z
dc.date.available2023-07-26T11:50:17Z
dc.date.issued2021
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.14309/01.ajg.0000798648.44410.c4
dc.identifier.issn1572-0241
dc.identifier.pmid34848599en_US
dc.identifier.scopus2-s2.0-85122428527en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS3en_US
dc.identifier.urihttps://doi.org/10.14309/01.ajg.0000798648.44410.c4
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12302
dc.identifier.volume116en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTokmak, Salih
dc.language.isoenen_US
dc.publisherNLM (Medline)en_US
dc.relation.ispartofThe American journal of gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.titleP012?Efficacy of Exclusive Enteral Nutrition and Weekly Adalimumab Combination in Crohn's Patients With Fibroinflammatory Stenosisen_US
dc.typeArticleen_US

Dosyalar